BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 18405179)

  • 1. Cutaneous T-cell lymphoma. Preface.
    Bagot M
    Dermatol Clin; 2008 Jan; 26 Suppl 1():V. PubMed ID: 18405179
    [No Abstract]   [Full Text] [Related]  

  • 2. Cutaneous T-cell lymphoma epidemiology: patients providing the power.
    Lessin SR
    Arch Dermatol; 2007 Jul; 143(7):916-8. PubMed ID: 17638738
    [No Abstract]   [Full Text] [Related]  

  • 3. Cutaneous T-cell lymphoma.
    Dalton JA; Yag-Howard C; Messina JL; Glass LF
    Int J Dermatol; 1997 Nov; 36(11):801-9. PubMed ID: 9427070
    [No Abstract]   [Full Text] [Related]  

  • 4. Is cutaneous T-cell lymphoma curable?
    Koh HK; Jacobson JO; Foss F; Lew RA
    Arch Dermatol; 1995 Sep; 131(9):1081-2. PubMed ID: 7661616
    [No Abstract]   [Full Text] [Related]  

  • 5. Advances in understanding the immunobiology and immunotherapy of cutaneous T-cell lymphoma.
    Berger CL; Mariwalla K; Girardi M; Edelson RL
    Adv Dermatol; 2004; 20():217-35. PubMed ID: 15544202
    [No Abstract]   [Full Text] [Related]  

  • 6. [Malignant lymphoma of the skin--especially cutaneous T-cell lymphoma].
    Nakajima H
    Nihon Hifuka Gakkai Zasshi; 1990 Nov; 100(13):1336-8. PubMed ID: 2079742
    [No Abstract]   [Full Text] [Related]  

  • 7. Cutaneous T-cell lymphoma: a model for selective immunotherapy.
    Edelson RL
    Cancer J Sci Am; 1998; 4(2):62-71. PubMed ID: 9532405
    [No Abstract]   [Full Text] [Related]  

  • 8. Cutaneous malignancies: KA, CTCL, and KS.
    Vargo N
    Dermatol Nurs; 2006 Jun; 18(3):270, 277. PubMed ID: 16856684
    [No Abstract]   [Full Text] [Related]  

  • 9. A case of poikiloderma vasculare atrophicans, a rare variant of cutaneous T-cell lymphoma, responding to extracorporeal photopheresis.
    Kreuter A; Hoffmamm K; Altmeyer P
    J Am Acad Dermatol; 2005 Apr; 52(4):706-8. PubMed ID: 15793532
    [No Abstract]   [Full Text] [Related]  

  • 10. What's new in dermatology? Cutaneous lymphoma.
    Piette W
    Iowa Med; 1991 May; 81(5):204. PubMed ID: 1869424
    [No Abstract]   [Full Text] [Related]  

  • 11. Cutaneous Lymphoma in Korea: A Nationwide Retrospective Study.
    Lee HS; Suh KS; Lee DY; Cho KH; Oh SH; Kim SC; Lee SJ; Shin DH; Yoon TY; Won YH; Kim YC
    Acta Derm Venereol; 2016 May; 96(4):535-9. PubMed ID: 26560051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of primary cutaneous T-cell lymphoma in Wales.
    Abbott RA; Aldridge C; Dojcinov S; Piguet V
    Br J Dermatol; 2013 Dec; 169(6):1366-7. PubMed ID: 23855741
    [No Abstract]   [Full Text] [Related]  

  • 13. Pediatric pityriasis lichenoides and cutaneous T-cell lymphoma.
    Lam J; Pope E
    Curr Opin Pediatr; 2007 Aug; 19(4):441-5. PubMed ID: 17630609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review of contemporaneous mycosis fungoides and B-cell malignancy at Mayo Clinic.
    Herro E; Dicaudo DJ; Davis MD; Weaver AL; Swanson DL
    J Am Acad Dermatol; 2009 Aug; 61(2):271-5. PubMed ID: 19481294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. cDNA microarrays: revolutionary technology for the diagnosis, prognosis, and treatment of cutaneous T-cell lymphoma.
    Hinshaw MA; Wood GS
    Int J Dermatol; 2005 Mar; 44(3):181-3. PubMed ID: 15807722
    [No Abstract]   [Full Text] [Related]  

  • 16. [Current approaches to diagnosing and treating primary cutaneous lymphomas on the basis of a new WHO-EORTC classification, cutaneous T-cell lymphomas].
    Belousova IE; Kazakov DV; Krivolapov IuA
    Arkh Patol; 2007; 69(5):11-7. PubMed ID: 18074813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunomodulatory therapy of cutaneous T-cell lymphoma: a multimodality approach in advanced disease.
    Junkins-Hopkins JM
    J Am Acad Dermatol; 2009 Dec; 61(6):1056-8. PubMed ID: 19925930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Standard and experimental therapy in cutaneous T-cell lymphomas.
    Dummer R; Cozzio A; Meier S; Beyeler M; Laetsch B; Doebbeling U; Urosevic M
    J Cutan Pathol; 2006 Feb; 33 Suppl 1():52-7. PubMed ID: 16412213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measuring HRQOL in patients with cutaneous T-cell lymphoma undergoing therapy with oral bexarotene and extracorporeal photopheresis.
    Demierre MF; Ferzli P; Miller D
    Arch Dermatol; 2007 May; 143(5):659-61. PubMed ID: 17515522
    [No Abstract]   [Full Text] [Related]  

  • 20. Introduction: cutaneous T-cell lymphoma (CTCL)--classification, staging, and treatment options.
    Bagot M
    Dermatol Clin; 2008 Jan; 26 Suppl 1():3-12. PubMed ID: 18405180
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.